Real-world effectiveness of palbociclib plus an aromatase inhibitor in HR+/HER2− MBC patients living in disadvantaged neighborhoods by Filipa Lynce, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Raymond Liu, Hope S. Rugo

Get full text

Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial trea... by Renee N Donahue, Jeffrey Schlom, Nicole J Toney, Claudine Isaacs, Filipa Lynce, Candace Mainor, Megan T Lynch

Get full text

Oncotype DX Recurrence Score and Germline BRCA Variants in Patients with HR-Positive/HER2-Negative Early Breast Cancer: A Retrospective Observational Study by Stefania Morganti, Rabia A. Khan, Luis C. Berrocal-Almanza, Miguel Miranda, Linlin Luo, Xiaoqing Xu, Ann H. Partridge, Filipa Lynce

Get full text

Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study by Ilana Schlam, Kelly A. Hirko, Daniela Shveid, Inas Abuali, Sarah Sewaralthahab, Faina Nakhils, Aditi Hazra, Csongor Lengyel, Sara Altuna, Sadaqat Hussain, Fahmi Seid, Sara Jamil, Andrew Odhiambo, Jose Pablo Leone, Otto Metzger, Jame Abraham, Enrique Soto-Perez-de-Celis, Wendy Y. Chen, Caroline Block, Susan Schumer, Jennifer R. Bellon, Carmine Valenza, Giuseppe Curigliano, Sara M. Tolaney, Filipa Lynce, Dario Trapani

Get full text